Bat influenza vectored NS1-truncated live vaccine protects pigs against heterologous virus challenge

被引:13
作者
Lee, Jinhwa [1 ]
Li, Yonghai [1 ]
Li, Yuhao [1 ]
Cino-Ozuna, A. Giselle [1 ]
Duff, Michael [1 ]
Lang, Yuekun [1 ]
Ma, Jingjiao [1 ]
Sunwoo, Sunyoung [1 ]
Richt, Juergen A. [1 ]
Ma, Wenjun [1 ,2 ,3 ]
机构
[1] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS USA
[2] Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO USA
[3] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO USA
关键词
Swine influenza vaccine; Bat influenza virus vectored live vaccine; Cross-protection; Heterologous virus challenge; Safety and efficacy; ENHANCED RESPIRATORY-DISEASE; T-CELL IMMUNITY; A VIRUS; IN-VIVO; SWINE; HEMAGGLUTININ; INFECTION; EFFICACY; PATHOGENICITY; RESPONSES;
D O I
10.1016/j.vaccine.2021.02.077
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Swine influenza is an important disease for the swine industry. Currently used whole inactivated virus (WIV) vaccines can induce vaccine-associated enhanced respiratory disease (VAERD) in pigs when the vaccine strains mismatch with the infected viruses. Live attenuated influenza virus vaccine (LAIV) is effective to protect pigs against homologous and heterologous swine influenza virus infections without inducing VAERD but has safety concerns due to potential reassortment with circulating viruses. Herein, we used a chimeric bat influenza Bat09:mH3mN2 virus, which contains both surface HA and NA gene open reading frames of the A/swine/Texas/4199-2/1998 (H3N2) and six internal genes from the novel bat H17N10 virus, to develop modified live-attenuated viruses (MLVs) as vaccine candidates which cannot reassort with canonical influenza A viruses by co-infection. Two attenuated MLV vaccine candidates including the virus that expresses a truncated NS1 (Bat09:mH3mN2-NS1-128, MLV1) or expresses both a truncated NS1 and the swine IL-18 (Bat09:mH3mN2-NS1-128-IL-18, MLV2) were generated and evaluated in pigs against a heterologous H3N2 virus using the WIV vaccine as a control. Compared to the WIV vaccine, both MLV vaccines were able to reduce lesions and virus replication in lungs and limit nasal virus shedding without VAERD, also induced significantly higher levels of mucosal IgA response in lungs and significantly increased numbers of antigen-specific IFN-gamma secreting cells against the challenge virus. However, no significant difference was observed in efficacy between the MLV1 and MLV2. These results indicate that bat influenza vectored MLV vaccines can be used as a safe live vaccine to prevent swine influenza. (C) 2021 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1943 / 1950
页数:8
相关论文
共 49 条
[41]   Haemagglutinin and nucleoprotein replicon particle vaccination of swine protects against the pandemic H1N1 2009 virus [J].
Vander Veen, R. L. ;
Mogler, M. A. ;
Russell, B. J. ;
Loynachan, A. T. ;
Harris, D. L. H. ;
Kamrud, K. I. .
VETERINARY RECORD, 2013, 173 (14) :344-+
[42]   Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine [J].
Vander Veen, Ryan L. ;
Loynachand, Alan T. ;
Mogler, Mark A. ;
Russell, Brandon J. ;
Harris, D. L. Hank ;
Kamrud, Kurt I. .
VACCINE, 2012, 30 (11) :1944-1950
[43]   Failure of protection and enhanced pneumonia with a USH1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine [J].
Vincent, Amy L. ;
Lager, Kelly M. ;
Janke, Bruce H. ;
Gramer, Marie R. ;
Richt, Juergen A. .
VETERINARY MICROBIOLOGY, 2008, 126 (04) :310-323
[44]   Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine [J].
Vincent, Amy L. ;
Ma, Wenjun ;
Lager, Kelly M. ;
Janke, Bruce H. ;
Webby, Richard J. ;
Garcia-Sastre, Adolfo ;
Richt, Juergen A. .
VACCINE, 2007, 25 (47) :7999-8009
[45]   Live Attenuated Influenza Vaccine Provides Superior Protection from Heterologous Infection in Pigs with Maternal Antibodies without Inducing Vaccine-Associated Enhanced Respiratory Disease [J].
Vincent, Amy L. ;
Ma, Wenjun ;
Lager, Kelly M. ;
Richt, Juergen A. ;
Janke, Bruce H. ;
Sandbulte, Matthew R. ;
Gauger, Philip C. ;
Loving, Crystal L. ;
Webby, Richard J. ;
Garcia-Sastre, Adolfo .
JOURNAL OF VIROLOGY, 2012, 86 (19) :10597-10605
[46]   Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs [J].
Vincent, Amy L. ;
Ciacci-Zanella, Janice R. ;
Lorusso, Alessio ;
Gauger, Philip C. ;
Zanella, Eraldo L. ;
Kehrli, Marcus E., Jr. ;
Janke, Bruce H. ;
Lager, Kelly M. .
VACCINE, 2010, 28 (15) :2782-2787
[47]   Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus [J].
Wesley, RD ;
Tang, M ;
Lager, KM .
VACCINE, 2004, 22 (25-26) :3427-3434
[48]   Pathogenicity of modified bat influenza virus with different M genes and its reassortment potential with swine influenza A virus [J].
Yang, Jianmei ;
Lee, Jinhwa ;
Ma, Jingjiao ;
Lang, Yuekun ;
Nietfeld, Jerome ;
Li, Yuhao ;
Duff, Michael ;
Li, Yonghai ;
Yang, Yuju ;
Liu, Haixia ;
Zhou, Bin ;
Wentworth, David E. ;
Richt, Juergen A. ;
Li, Zejun ;
Ma, Wenjun .
JOURNAL OF GENERAL VIROLOGY, 2017, 98 (04) :577-584
[49]   Characterization of Uncultivable Bat Influenza Virus Using a Replicative Synthetic Virus [J].
Zhou, Bin ;
Ma, Jingjiao ;
Liu, Qinfang ;
Bawa, Bhupinder ;
Wang, Wei ;
Shabman, Reed S. ;
Duff, Michael ;
Lee, Jinhwa ;
Lang, Yuekun ;
Cao, Nan ;
Nagy, Abdou ;
Lin, Xudong ;
Stockwell, Timothy B. ;
Richt, Juergen A. ;
Wentworth, David E. ;
Ma, Wenjun .
PLOS PATHOGENS, 2014, 10 (10)